Page last updated: 2024-09-03

3-n-methylspiperone and Chronic Illness

3-n-methylspiperone has been researched along with Chronic Illness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dannals, RF; Pearlson, G; Ravert, HT; Sapp, J; Shaya, EK; Strauss, M; Tune, LE; Wilson, AA; Wong, DF; Young, T1

Other Studies

1 other study(ies) available for 3-n-methylspiperone and Chronic Illness

ArticleYear
Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone.
    Psychiatry research, 1993, Volume: 49, Issue:3

    Topics: Adult; Carbon Radioisotopes; Chronic Disease; Cohort Studies; Corpus Striatum; Dopamine Agents; Female; Humans; Male; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Spiperone; Tomography, Emission-Computed

1993